Cutera Laser System for Hair Loss
What You Need to Know Before You Apply
What is the purpose of this trial?
The objective is to evaluate the safety and efficacy of the Cutera 1726 nm laser system (also referred to as AviClear) for the treatment of facial papules in frontal fibrosing alopecia (FFA).
Are You a Good Fit for This Trial?
This trial is for adults with diagnosed frontal fibrosing alopecia (FFA) featuring facial papules. Participants must have no issues with laser therapy, be able to follow the study's schedule and care instructions, and consent to use only approved skincare products during the trial. They should also agree to photo documentation.Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive the 1726 nm laser treatment for facial papules in frontal fibrosing alopecia
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Cutera® 1726 nm laser system
Trial Overview
The Cutera 1726 nm laser system, known as AviClear, is being tested for its safety and effectiveness in treating facial papules associated with FFA. The study will monitor how well this specific laser technology works on participants' skin conditions.
How Is the Trial Designed?
1
Treatment groups
Experimental Treatment
Participants will be in this group for up to approximately 30 weeks and complete up to 5 visits
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Miami
Lead Sponsor
Cutera Inc.
Industry Sponsor
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.